Latest News

  • Researchers Build Pediatric Cancer Atlas, Envision Universal Diagnostic Potential

    Diagnostics World | Whereas some detection and diagnosis tools search for mutations in certain genes or analyze the genome, an international group of researchers spanning Canada, the UK, and Australia has created an atlas of pediatric cancer using a machine-learning algorithm that considers the whole transcriptome.

    May 9, 2023
  • Accelerating Implementation: Unlocking the Potential of Next-Generation Sequencing

    Diagnostics World News | Next-generation sequencing (NGS) has revolutionized molecular biology and served as a universal tool for many research avenues across the spectrum of biology. With the NGS market expanding, three key barriers—time, cost, and expertise—are holding back the potential of NGS and the full impact it could have on society, diagnostics, and precision medicine.

    May 5, 2023
  • Novel Sensor Measures What Your Smartwatch Can’t: Muscle

    Diagnostics World News | The first-ever wearable sensor for monitoring muscle atrophy has been developed by researchers at The Ohio State University thanks to an interest in the muscle-shrinking condition by NASA, which has been funding most of the work to date.

    May 4, 2023
  • Rapid Testing Platform For Mpox Extensible To Other Emerging Pathogens

    Diagnostics World News | Researchers at Pennsylvania State University are leading the development of a lateral flow assay for mpox (monkeypox), which in another few years could join pregnancy tests on retail pharmacy shelves. The more immediate plan is to produce a rapid, point-of-care (POC) test for low-resource settings that involves a smartphone or other small reader capable of differentiating mpox from smallpox based on the light bouncing back from gold nanoparticles underpinning the platform.

    May 2, 2023
  • Diagnostics News from Oxford Nanopore, Vizgen, BGI Genomics, More

    Diagnostics World News | Oxford Nanopore enters the diagnostics market with bioMérieux collaboration, BGI Genomics agrees to tech transfer in southern Africa, and more. Plus new products from Vizgen, Agilent, Capitainer, and Metabolon.

    Apr 27, 2023
  • Follow the Money: Cancer Biomarker Detection, Gastrointestinal Diagnosis, More

    Diagnostics World News | Mercy BioAnalytics nets Series A for detecting cancer biomarkers on the surface of tumor-derived extracellular vesicles; Gilde Healthcare announces a new fund for medtech; using gas-sensing capsule to assess gastrointestinal motility; and more.

    Apr 25, 2023
  • Predictive Model For Gestational Diabetes Heads To Clinical Trials

    Diagnostics World | An international team of researchers has found that gut microbes can help diagnose gestational diabetes mellitus (GDM) as early as the first trimester of pregnancy, months earlier than is happening currently. The long-term aim of the group is to predict and prevent one of the most common pregnancy-related medical complications with adverse health implications for mother and child.

    Apr 19, 2023
  • Army Researchers Identify Blood Biomarker Panel For PTSD

    Diagnostics World News | Post-traumatic stress disorder is difficult to diagnose under the best of conditions, including knowing the triggering issues and how an individual responds to stressful events. For the mostly young and “macho” men in the military who are exposed to combat and separated from their families for many months at a stretch the obstacles—and stakes—are even higher.

    Apr 18, 2023
  • AI-Based Retinal Aging Clock Gauges Effectiveness Of Anti-Aging Interventions

    Diagnostics World News | Retinal scans offer a fascinating window into the health of the body’s circulatory system and brain functioning as well as identify eye diseases that aren't visibly noticeable. Now, a new study suggests that this artificial intelligence-based technology is also good for predicting how well people are aging.

    Apr 13, 2023
  • Global Collaboration Enables Headway On Rare Neuroendocrine Tumors

    Diagnostics World News | Researchers in Madrid recently wrapped up the largest-yet genomic study of rare neuroendocrine tumors, known as pheochromocytomas and paragangliomas, which identified a seemingly perfect panel of metastatic disease markers as well as a group of patients who could potentially benefit from immunotherapy. The objective here is a better means to predict, at the time of diagnosis of the primary tumor, whether patients will be immediately affected by cancer spread.

    Apr 11, 2023
  • NIH-Supported Studies Reveal Possible Long COVID Disparities

    Diagnostics World News | Two recent studies funded by NIH’s Researching COVID to Enhance Recovery (RECOVER) Initiative reveal differences in long COVID diagnostic experiences among different racial and ethnic groups. The findings provide information about variations in symptoms and access to care.

    Apr 6, 2023
  • Liquid Biopsies Could Help Speed Up Lung Cancer Clinical Trials

    Diagnostics World News | Circulating tumor DNA (ctDNA) holds potential as a biomarker in lung cancer clinical trials as an added and easier-to-monitor endpoint to survival rates for measuring treatment efficacy. This was one of the key findings of her most recent work, where ctDNA was also shown to outperform clinical responses assessed on CT scans in the prediction of survival.

    Apr 5, 2023
  • Illumina Releases International Version of Tertiary Clinical NGS Analysis Software

    Diagnostics World News | Illumina has released Connected Insights, a cloud-based software for tertiary analysis for clinical next-generation sequencing (NGS) data. The software is commercially available in a limited number of countries and in beta testing in the US.

    Apr 4, 2023
  • CLIA-Certified Personalized Blood Test for Multiple Myeloma, Wearable Sensor Detects Blood Biomarker for Heart Attacks, More

    Diagnostics World News | Personalized treatment for high-risk patients with asthma and chronic obstructive pulmonary disease to improve their health outcomes; state-of-the-art AI algorithms provide a real-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients; bioelectronic sensors that will aid in cheap, accurate, and rapid pathogen detection; and more.

    Mar 30, 2023
  • Follow the Money: Bill & Melinda Gates Foundation Fund Diagnostic Breathalyzer, European Innovation Council Backs New RNA-Based Therapies and Diagnostics, More

    Diagnostics World News | Funding for targeting extracellular proteins involved in the pathogenesis of autoimmune, neurological, and other diseases, rapid screening of infectious diseases through volatile organic compounds, a proteomics AI-based platform that comprehensively maps the course of a disease to predict which patients will respond to a given drug, and more.

    Mar 28, 2023
  • Japanese Medical Team Discovers Gut Microbiota to Diagnose and Treat Dementia with Lewy Bodies

    Diagnostics World News | A research team from the Nagoya University Graduate School of Medicine, Japan, discovered three gut bacteria types that may lead to predicting and treating dementia with Lewy bodies.

    Mar 23, 2023
  • Lupus Patients Can Expect At-Home Test For Kidney Inflammation

    Diagnostics World News | A smartphone-based app and test kit for lupus nephritis may start making its way to neighborhood CVS and Walgreens stores in another few years. The urine test has been shown to detect the protein ALCAM (activated leukocyte cell adhesion molecule) to distinguish lupus patients with and without the condition with 86% accuracy in multiple cohorts.

    Mar 22, 2023
  • Coronary Heart Disease Can Now Be Detected Early In The Blood

    Diagnostics World News | The worlds of genetics, epigenetics, and artificial intelligence have united to enable development of a blood test for the early detection of coronary heart disease. Newly launched in the U.S. by Cardio Diagnostics, PrecisionCHD is underpinned by the same technology as the company’s predecessor Epi+Gen CHD risk assessment test but using a different set of genetic and DNA methylation biomarkers.

    Mar 21, 2023
  • MRD in 2023: Current Capabilities, Differing Approaches, and Tests on the Horizon

    Diagnostics World News | An array of diagnostics companies have set their sights on developing minimal residual disease tests capable of detecting low levels of cancer cells remaining in the body following surgery or other types of treatment. The aim is to help measure response to therapy and identify patients at risk of relapse.

    Mar 16, 2023
  • New Telomere Measuring Method Addressing Limitations Of Current Options

    Diagnostics World News | A research collaboration led by led by Duke-NUS Medical School and National Heart Centre Singapore has set the stage for telomere measurement to one day be added to the list of clinical-grade methods for assessing biological aging. The focus is on rapid and precise measurement of individual telomeres using a technique that employs “telobaits” that latch onto the ends of telomeres in large pools of DNA fragments.

    Mar 14, 2023